Physicians' Academy for Cardiovascular Education

Emerging therapeutic areas in lipid management and CV disease

Mar. 16, 2017 - VBWG - ACC 2017 - Sotirios Tsimikas - La Jolla, CA, USA

VBWG ACC 2017 Sotirios Tsimikas summarises the rationale of innovative therapeutic approaches targeting Lp(a), ApoC3 or ATP citric lyase and in what stage of clinical testing they currently are.

Educational information

This video was recorded after the Vascular Biology Working Group Meeting at ACC 2017, in Washington, DC, USA.

PACE-cme did not receive financial support for the production of this video.

Faculty & Disclosures

Sotirios “Sam” Tsimikas - Professor of Medicine, Director of Vascular Medicine, Division of Cardiovascular Diseases, Department of Medicine, UCSD Cardiology La Jolla, Perlman, CA, USA